By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Thursday that its second-quarter revenues increased around 28 percent, but its net loss jumped 64 percent on higher spending.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $516,803 for the three-month period ended June 30, up from $402,237 for the second quarter of 2009. It fell short of analysts' consensus estimate for revenues of $880,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.